Provided by Tiger Trade Technology Pte. Ltd.

BIOTRON LIMITED

0.003
0.000-14.29%
Volume:3.01M
Turnover:9.02K
Market Cap:8.11M
PE:-9.43
High:0.003
Open:0.003
Low:0.003
Close:0.004
52wk High:0.010
52wk Low:0.002
Shares:2.70B
Float Shares:1.16B
Volume Ratio:1.49
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.000
EPS(LYR):0.000
ROE:-206.96%
ROA:-28.73%
PB:14.69
PE(LYR):-9.43

Loading ...

Company Profile

Company Name:
BIOTRON LIMITED
Exchange:
ASX
Establishment Date:
1999
Employees:
3
Office Location:
66 Hunter Street,Level 2,Sydney,New South Wales,Australia
Zip Code:
2000
Fax:
61 2 9221 6333
Introduction:
Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.